 |
|
COPD? Eat your veggies
September 12, 2008You know it's good for you in other ways, but could eating your broccoli also help patients with chronic lung disease? It just might.
According to recent research from Johns Hopkins Medical School, a decrease in lung concentrations of NRF2-dependent antioxidants, key components of the lung's defense system against inflammatory injury, is linked to the severity of chronic obstructive pulmonary disease (COPD) in smokers. Broccoli is known to contain a compound that prevents the degradation of NFRP.
The findings were published in the second issue for September of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society.
COPD is the fourth-leading cause of death in the U.S. and affects more than 16 million Americans.
In this study, researchers examined tissue samples from the lungs of smokers with and without COPD to determine if there were differences in measured levels of NRF2 expression and the level of its biochemical regulators, including KEAP1, which inhibits NRF2, and DJ-1, which stabilizes it. Dr. Biswal had previously shown that disruption in NRF2 expression in mice exposed to cigarette smoke caused early onset of severe emphysema.
When compared to non-COPD lungs, the lungs of patients with COPD showed markedly decreased levels of NRF2-dependent antioxidants, increased oxidative stress markers, a significant decrease in NRF2 protein with no change in NRF2 mRNA levels (indicating that it was expressed, but subsequently degraded), and similar KEAP1 levels, but a marked decrease in the level of DJ-1.
"NRF2-dependent antioxidants and DJ-1 expression was negatively associated with severity of COPD," wrote principle investigator, Shyam Biswal, Ph.D., an associate professor in the Bloomberg School's Department of Environmental Health Sciences and Division of Pulmonary and Critical Care at the Johns Hopkins School of Medicine. "Therapy directed toward enhancing NRF2-regulated antioxidants may be a novel strategy for attenuating the effects of oxidative stress in the pathogenesis of COPD."
While clinical trials to date of antioxidants have been disappointing in improving the clinical course of patients with COPD, this study points to a possibility of benefit from restoring NRF2 levels in damaged lungs by reducing the action of KEAP1, which is an inhibitor of NRF2. "[I]ncreasing NRF2 may also restore important detoxifying enzymes to counteract other effects of tobacco smoke," wrote Peter Barnes, D.M., of the National Heart and Lung Institute in London, in the accompanying editorial. "This has been achieved in vitro and in vivo by isothiocynate compounds, such as sulforaphane, which occurs naturally in broccoli and [wasabi]."
Sulforapane has been shown to be able to restore antioxidant gene expression in human epithelial tissue in which DJ-1 has been reduced. Isothicyanate compounds such as that found in broccoli inhibit KEAP1, and thus prevent it from degrading NRF2, according to Dr. Barnes.
"Future studies should target NRF2 as a novel strategy to increase antioxidant protection in the lungs and test its ability to decrease exacerbations and improve lung function in patients with COPD," concluded Dr. Biswal.
John Heffner, MD, past president of the ATS, commented that "mounting evidence over several decades underscores the importance of oxidant-mediated damage for the development of COPD in addition to other lung diseases. This study adds greater precision to our understanding of the specific antioxidants that may protect the lung against emphysema to allow clinical trials based on valid pathophysiologic principles."
You know it's good for you in other ways, but could eating your broccoli also help patients wit
COPD is the fourth-leading cause of death in the U.S. and affects more than 16 million Americans.
In this study, researchers examined tissue samples from the lungs of smokers with and without COPD to determine if there were differences in measured levels of NRF2 expression and the level of its biochemical regulators, including KEAP1, which inhibits NRF2, and DJ-1, which stabilizes it. Dr. Biswal had previously shown that disruption in NRF2 expression in mice exposed to cigarette smoke caused early onset of severe emphysema.
When compared to non-COPD lungs, the lungs of patients with COPD showed markedly decreased levels of NRF2-dependent antioxidants, increased oxidative stress markers, a significant decrease in NRF2 protein with no change in NRF2 mRNA levels (indicating that it was expressed, but subsequently degraded), and similar KEAP1 levels, but a marked decrease in the level of DJ-1.
"NRF2-dependent antioxidants and DJ-1 expression was negatively associated with severity of COPD," wrote principle investigator, Shyam Biswal, Ph.D., an associate professor in the Bloomberg School's Department of Environmental Health Sciences and Division of Pulmonary and Critical Care at the Johns Hopkins School of Medicine. "Therapy directed toward enhancing NRF2-regulated antioxidants may be a novel strategy for attenuating the effects of oxidative stress in the pathogenesis of COPD."
While clinical trials to date of antioxidants have been disappointing in improving the clinical course of patients with COPD, this study points to a possibility of benefit from restoring NRF2 levels in damaged lungs by reducing the action of KEAP1, which is an inhibitor of NRF2. "[I]ncreasing NRF2 may also restore important detoxifying enzymes to counteract other effects of tobacco smoke," wrote Peter Barnes, D.M., of the National Heart and Lung Institute in London, in the accompanying editorial. "This has been achieved in vitro and in vivo by isothiocynate compounds, such as sulforaphane, which occurs naturally in broccoli and [wasabi]."
Sulforapane has been shown to be able to restore antioxidant gene expression in human epithelial tissue in which DJ-1 has been reduced. Isothicyanate compounds such as that found in broccoli inhibit KEAP1, and thus prevent it from degrading NRF2, according to Dr. Barnes.
"Future studies should target NRF2 as a novel strategy to increase antioxidant protection in the lungs and test its ability to decrease exacerbations and improve lung function in patients with COPD," concluded Dr. Biswal.
John Heffner, MD, past president of the ATS, commented that "mounting evidence over several decades underscores the importance of oxidant-mediated damage for the development of COPD in addition to other lung diseases. This study adds greater precision to our understanding of the specific antioxidants that may protect the lung against emphysema to allow clinical trials based on valid pathophysiologic principles."
You know it's good for you in other ways, but could eating your broccoli also help patients wit
Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Spinal Cord Coral reef Insecticide Fatigue Circadian Clock Archaea Oxygen Food Poisoning Fruit Flies Preterm Birth Molecular Imaging Microfluidic device Clostridium difficile Curcumin Fingerprints Clinical Trial Auditory Cortex Rotator Cuff Arsenic Cavities Hygiene Climate Changes Kidney Stones Motor Neurons Copd
See More: Science News Tags
COPD Current Events and COPD News RSSNew American College of Surgeons risk calculator determines colorectal surgery risk
New research published in the June issue of the Journal of the American College of Surgeons shows that a risk calculator developed by the American College of Surgeons (ACS) can help surgeons provide patients with more detailed and accurate preoperative information about the risk of death and complications following colorectal surgery.
Top notch decisions in the developing airways bring insights into lung disease
In the normal lung, the airways are lined by a balanced mixture of ciliated, secretory and neuroendocrine cells which perform functions as diverse as air humidification, detoxification, and clearance of environmental particles.
Investigation finds that cigarette smoking does not affect everyone in same way
Cigarette smoking induced COPD, or chronic obstructive pulmonary disease, is a disease that results in severe breathing difficulty.
Vitamin D may halt lung function decline in asthma and COPD
Vitamin D may slow the progressive decline in the ability to breathe that can occur in people with asthma as a result of human airway smooth muscle (HASM) proliferation, according to researchers at the University of Pennsylvania.
Lifestyle program for patients with COPD is health and cost effective
Patients with moderate COPD were randomized to receive "usual care" or to undergo an interdisciplinary, community-based program (INTERCOM) that offered an intensive lifestyle moderation phase of four months, during which patients were instructed in detail to perform two 15-minute intervals of pleasurable walking or cycling, and offered instruction in other lifestyle changes such as nutrition and smoking cessation.
Self-treatment results in lower overall health care costs for COPD sufferers
Individuals suffering from chronic obstructive pulmonary disorder (COPD) can experience significant savings in healthcare costs by employing a self-treatment program with the judicious use of medications.
Marijuana smoking increases risk of COPD for tobacco smokers
Smoking both tobacco and marijuana increases the risk of respiratory symptoms and chronic obstructive pulmonary disease (COPD). Smoking only marijuana, however, was not associated with increased risks.
Cigarette smoke may alter immune response in COPD exacerbations
Smoking cigarettes is not only the principle cause of chronic obstructive pulmonary disease (COPD), but it may change the body's immune responses to bacteria that commonly cause exacerbations of the disease, according to new research in a mouse model.
Supervised exercise therapy can lead to improvements in COPD symptoms
Those suffering from chronic obstructive pulmonary disease (COPD) often complain that exercise is too exhausting and leaves them breathless.
Changes in gene may stunt lung development in children
Mutations in a gene may cause poor lung development in children, making them more vulnerable to diseases such as chronic obstructive pulmonary disease (COPD) later in life, say researchers at the University of Pittsburgh Graduate School of Public Health and the German Research Center for Environmental Health.
More COPD Current Events and COPD News Articles
 |
Natural Therapies for Emphysema and COPD: Relief and Healing for Chronic Pulmonary Disorders by Robert J. Green Jr. (Author) The first book to address emphysema and chronic obstructive pulmonary disease (COPD) from a nutritional and alternative medicine approach • Explains the benefits of detoxification, dietary changes, and food combining • Details 45 suggested herbs and 26 nutritional supplements as well as information on how to stop smoking Approximately 35 million people in the United States have been diagnosed with some form of chronic obstructive pulmonary disease (COPD)--emphysema constituting 18 million of that group. Worldwide, as many as 293 million people suffer with these conditions. COPD is the fourth leading cause of death in America, claiming nearly 120,000 lives annually. Yet conventional approaches to treatment, with their regimens of drugs and unceasing... |
 |
COPD: The Struggle To Breath Part of the award winning public television series Healthy Body/Healthy Mind. Chronic Obstructive Pulmonary Disease is an umbrella term used to describe patients with Chronic Bronchitis and/or Emphysema. The condition causes shortness of breath and can restrict mobility, making simple tasks like walking to the car seem almost impossible. Learn more about this chronic disease and how to cope with the condition. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
Microlife PF 100 Peak Flow Meter for Spirometry with FEV1 by Microlife This device is used to measure Peak Expiratory Flow (PEF) and Forced Expiratory Volume in 1-second (FEV1) in both children and adults. PEF is the fastest speed air can be blown out of the lungs after inhalation. FEV1 measures the volume after exhaling in 1-second. Peak Flow (PEF) and Forced Expiratory Volume in 1-second (FEV1) measurements can tell how well lungs are breathing by monitoring airflow. Doctors can have patients monitor changes in airflow and record the results. The automatic memory stores and provides easy access to the last 240 readings along with the time and date. |
 |
COPD For Dummies (For Dummies (Health & Fitness)) by Kevin Felner MD (Author), Meg Schneider (Author) Make your home COPD friendly Your reassuring guide to understanding and managing COPD Want to know more about COPD? This straightforward guide provides clear information about this progressive disease, explaining how to recognize the warning signs, get diagnosed, and choose the best treatment. You'll see how diet, exercise, and medication affect your symptoms and make your life easier. Discover how to: Know your risk factors Find the right doctors Quit smoking, start exercising, and change your diet Improve your overall health Prepare for emergencies Help loved ones with COPD |
 |
COPD/Asthma Starring: Suzanne Andrews Directed By: Virgil Taylor Choose Your Level: Seated or Standing Bonus Segment:Medical Matters Asthma Show Energy Conservation techniques that teach you easier ways to: *Breath *Cook *Play with your pet (FUN!) *Groom As Seen on Public Television! COPD is a lung disease that limits airflow and causes shortness of breath. Normally easy tasks like walking to the car, having a shower and performing household duties can make the simple task of breathing very difficult. If you or a loved one live with asthma, bronchitis or emphysema, this medically engineered program can help: 1. Improve your ability to breathe 2. Increase your enjoyment to participate in daily activities. 3. Release stress Suzanne Andrews, an Occupational Therapy Practitioner and Host... |
 |
Coping with COPD: Understanding, Treating, and Living with Chronic Obstructive Pulmonary Disease by Elaine Fantle Shimberg (Author), Thomas L. Petty M.D. (Foreword) The first hands-on guide to living and coping with an insidious disease that affects tens of millions of people Experts estimate that as many as thirty-five million Americans literally cannot catch their breath-they are suffering from Chronic Obstructive Pulmonary Disease. The fourth-leading cause of death in America, COPD is a combination of chronic bronchitis and emphysema with airflow obstruction. In this clear, concise, and up-to-date guide to dealing with and living well with COPD, readers will learn: - How to navigate activities of daily living, from applying make-up to continuing work - How to quite smoking-at any age - How oxygen therapy may help you - How to tailor diet to meet new nutritional needs - How to foster a useful patient/doctor... |
 |
HOW TO BE FREE OF ALCOHOLISM, CANCER AND MANY OTHER DISEASES by NORTHERNLIGHTS ENTERPRISES, LLC This book provides an easy way to maintain an exceptionally strong immune system capable of warding off many major and minor diseases, including alcoholism, cancer, depression, and many others. This is breakthrough technology that will have a major impact on your pharmaceutical and health care costs. It can have an almost immediate positive impact on your health. The cost of this book can be recovered very quickly by savings in health care. |
|
Sit and Be Fit:Copd [VHS] Starring: Mary Ann Wilson | |
 |
100 Questions & Answers About COPD by Campion E. Quinn (Author) Chronic Obstructive Pulmonary Disease, or COPD, is a disabling and potentially fatal illness affecting more than 13 million people and is the fifth leading cause of death in the United States. Whether you or a loved one has been diagnosed with COPD, the number and type of diagnosis and treatment options can be overwhelming. This invaluable resource offers the guidance and advice you need. Written by a prominent physician and leader in patient support for this devastating lung disease, with commentary from an actual COPD patient, 100 Questions & Answers About Chronic Obstructive Pulmonary Disease gives you authoritative, practical answers to your questions, including diagnosis, medical, surgical, and rehabilitative treatment options, how to work with your physician to improve your health... |
 |
FlameEz-Lung, 60 Capsules/Bottle by FlameEz Chronic Obstructive Pulmonary Disease (COPD) is progressive inflammatory disease affecting the respiratory tract and the lungs. Inflammation causes destruction of airways and lung tissues. If inflammation persists, the damage to the airways and lungs may not be reversed. Recent studies also suggest that inflammation is a critical component in lung cancer development, progression and metastasis. Inflammation induces the release of a variety of inflammatory cytokines that cause oxidative damage, DNA mutation, and cell transformation. Inflammation also plays a key role in survival and expansion of tumor cells. Since tumor cells produce various substances that attract inflammatory cells, which are indispensable participants in tissue disruption and metastasis, inflammation has been described... |
| © 2009 BrightSurf.com |